[12] |
刘娟,肖政辉.N端B型脑钠肽在脓毒症中的研究进展[J].中国医师杂志,2013,15(6):861-864.
|
[1] |
Esper AM,Martin GS.Extending international sepsis epidemiology:the impact of organ dysfunction[J].Crit Care,2009,13(1):148-150.
|
[2] |
吴连春.前列地尔的临床应用进展[J].河北联合大学学报(医学版),2013,15(2):185-187.
|
[3] |
Dellinger RP,Levy MM,Andrew Rhodes,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012[J].Crit Care Med,2013,41(2):580-637.
|
[4] |
陈坤.常用危重症评分在脓毒症预后评价中的应用[J].中国急救医学,2014,34(8):679-682.
|
[7] |
张晓凡,李莉.脓毒症心肌损伤机制研究及治疗进展[J].中华急诊医学杂志,2015,24(3):339-341.
|
[8] |
杨乐,邹晓静,李树生,等.脓毒症心肌抑制研究进展[J].内科急危重症杂志,2010,16(1):46-48.
|
[9] |
王素美,吴志峰,刘艳萍.前列腺素E1对肺源性心脏病心力衰竭患者临床疗效的观察[J].临床肺科杂志,2008,13(3):743.
|
[10] |
张竞超,吴立文,郎艳,等.前列地尔对冠状动脉搭桥术后患者心肺功能的影响[J].中华实验外科杂志,2014,31(2):435-437.
|
[11] |
许强,张健,王士雯.老年重度脓毒症合并心肌抑制患者心肌损伤标记物变化及价值[J].山东医药,2005,45(4):15-17.
|
[5] |
Flierl MA,Rittirsch D,Huber-Lang MS,et al.Molecular events in the cardiomyopathy of sepsis[J].Mol Med,2008,14(5/6):327-336.
|
[6] |
Vieillard-Baron A,Caille V,Charron C,et al.Actual incidence of global left ventricular hypokinesia in adult septic shock[J].Crit Care Med,2008,36(6):1701-1706.
|
[13] |
Bouhemad B,Nicolas-Robin A,Arbelot C,et al.Acute left ventricular dilatation and shock-induced myocardial dysfunction[J].Crit Care Clin,2009,37(2):441-447.
|
[14] |
李丽娟,阮冬石,刘国梁,等.cTnI和NT-proBNP联合APACHEⅡ评分在评估老年感染性休克患者预后中的价值[J].中国急救医学,2015,35(4):297-300.
|